Hatch BioFund Management LLC and Brandywine Realty Trust announced a new partnership to support the advancement of life sciences companies in Greater Philadelphia. Philadelphia has long been a city recognized around the globe for its world-class research institutions and clinical expertise. This reputation was further strengthened by the recent clinical success of advanced therapies being forged in the city, including the first FDA-approved cell and gene therapies and the Nobel Prize-winning research that led to the development of highly effective, mRNA-based Covid-19 vaccines.

Additionally, Philadelphia was recently named one of five regions in the country to receive a biotechnology hub designation from the Biden administration.